0 COVID-19: Updates on vaccines and therapeutics
Take a look at our day-by-day updates covering the latest on therapeutics and vaccines for COVID-19, from new partnerships to clinical trials..
Browsing: Clinical > Vaccines
0 Vaccination and the immunocompromised population – an interview with Deepali Kumar
In this interview we speak to Deepali Kumar about vaccination in the immunocompromised population, including guideline updates, understanding immunology and the future of this field.
0 COVID-19: First patients dosed in Phase I vaccine trial
Moderna has announced that the first participants have been dosed in a Phase I study of their mRNA candidate vaccine against SARS-CoV-2, the virus that causes COVID-19.
0 Universal vaccines: A holy grail for the flu?
In this blog, we review some of the main targets of universal vaccines and the key challenges to their successful implementation.
0 Could obesity promote virulence in influenza?
A mouse study has revealed that obesity may be one factor explaining the significant amount of variation in the influenza virus each year, likely due to an impaired interferon defense response.
0 The race for COVID-19 treatments and vaccines: February’s industry headlines
Catch up on February’s industry headlines, including an MRSA breakthrough, a patent lawsuit, and the latest updates on the coronavirus outbreak and its impact on the biotechnology industry worldwide.
0 Clinical trial of experimental HIV vaccine halted
The National Institute of Allergy and Infectious Diseases has stopped administering an experimental HIV vaccine in the South Africa HVTN 702 clinical trial, after an independent data and safety monitoring board has found that the vaccine is ineffective at preventing HIV infection.
2 Could tailor-made vaccines halve rates of serious Streptococcus pneumoniae infection?
Optimizing vaccine models for Streptococcus pneumoniae suggests that vaccine programs need to be tailored to target specific subgroups including age and geographical region.
0 FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
Take a look at the industry headlines from the last 2 months, including the FDA approval of Ebola vaccine Ervebo,…
0 Changing the administration of the BCG vaccine could improve efficacy
Administering the BCG vaccine intravenously, as opposed to intradermally, could improve the efficacy of the immunization according to new research in macaque models.
